Yahoo! News: Business
Reuters - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.
Reuters: Business News
TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.
WSJ.com: What's News US
Teva raised its full-year outlook after announcing its launch of generic equivalents to Wyeth's Protonix, an acid-reflux treatment. Wyeth said it will pursue a patent-infringement claim for lost profits and other damages.